Science Explorer Back to mapMap

Trigeminal Neuralgia and Treatments

Trigeminal Neuralgia and Treatments is a research topic within Pathology and Forensic Medicine. Science Explorer counts 15k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the pathology, pathogenesis, diagnosis, and management of trigeminal neuralgia, with an emphasis on microvascular decompression and radiosurgery as treatment modalities. It also explores the role of neurovascular compression, neuropathic pain, and the pathophysiology of trigeminal neuralgia.

  • Trigeminal Neuralgia
  • Microvascular Decompression
  • Radiosurgery
  • Neurovascular Compression
  • Pathophysiology
  • Diagnosis
  • Treatment
  • Neuropathic Pain
  • Gamma Knife
  • Neurological Surgery
Research works
15k
fractional, since 1950
In the world top 10%
1.5k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+16%
the tick is no change
Largest producer
United States
33% of the 10 largest, 2022-now
Trigeminal Neuralgia and Treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Trigeminal Neuralgia and Treatments research?

By volume, the United States and China publish the most (758 and 424 works in 2022-now).

By volume, 2022-now

  1. 1 United States 758 works
  2. 2 China 424 works
  3. 3 India 220 works
  4. 4 Japan 187 works
  5. 5 Türkiye 146 works
  6. 6 Italy 144 works
  7. 7 South Korea 124 works
  8. 8 Germany 115 works
  9. 9 Brazil 105 works
  10. 10 United Kingdom 103 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 32.6%China: 18.2%India: 9.4%Japan: 8.0%6 others listed: 31.7%33%largest
United States758 · 32.6%China424 · 18.2%India220 · 9.4%Japan187 · 8.0%6 others listed736 · 31.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Trigeminal Neuralgia and Treatments research?

By volume in 2022-now, Harvard University publishes the most Trigeminal Neuralgia and Treatments research, followed by Mayo Clinic and Capital Medical University.

Who are the leading researchers in Trigeminal Neuralgia and Treatments?

The most-cited researchers publishing on Trigeminal Neuralgia and Treatments include Karl John Friston and Isabela M. Benseñor.

  1. 1 Karl John Friston United Kingdom 310k citations
  2. 2 Isabela M. Benseñor Brazil 245k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Trigeminal Neuralgia and Treatments?

The most cited paper in Trigeminal Neuralgia and Treatments is "Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996" (Eric M. Wassermann, 1998), with 2,311 citations. Next come "Pathophysiology of Migraine: A Disorder of Sensory Processing" (2,059) and "Migraine — Current Understanding and Treatment" (1,936).

Most cited papers
#PaperReleasedCitations
1 Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996 Eric M. Wassermann · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section 1998 2,311
2 Pathophysiology of Migraine: A Disorder of Sensory Processing Peter James Goadsby, Philip Robert Holland, Margarida Martins-Oliveira et al. · Physiological Reviews ReviewOpen access 8 Feb 2017 2,059
3 Migraine — Current Understanding and Treatment Peter James Goadsby, Richard B. Lipton, Michel D. Ferrari · New England Journal of Medicine 24 Jan 2002 1,936
4 EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision Nadine Attal, G. Cruccu, Ralf Baron et al. · European Journal of Neurology Open access 7 Apr 2010 1,881
5 Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment Ralf Baron, Andreas Binder, Gunnar L. Wasner · The Lancet Neurology 21 Jul 2010 1,829
All 100 most cited papers, with filters and sorting

Where is Trigeminal Neuralgia and Treatments research done?

The largest centres of Trigeminal Neuralgia and Treatments research in 2022-now are Beijing (China), Seoul (South Korea), Tokyo (Japan) and Istanbul (Türkiye). Among places with at least 20 works in it, it is an unusually large share of all research in Rockville Centre and Cleveland.

Largest cities, 2022-now

  1. 1 BeijingChina 71 works
  2. 2 SeoulSouth Korea 66 works
  3. 3 TokyoJapan 50 works
  4. 4 IstanbulTürkiye 46 works
  5. 5 ShanghaiChina 44 works
  6. 6 LondonUnited Kingdom 42 works
  7. 7 New YorkUnited States 37 works
  8. 8 São PauloBrazil 34 works
  9. 9 MoscowRussia 33 works
  10. 10 RomeItaly 32 works

Where it is the local speciality

  1. Rockville CentreUS · 22.7 works51×
  2. ClevelandUS · 25.3 works5.6×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Trigeminal Neuralgia and Treatments than the world average.

See Trigeminal Neuralgia and Treatments on the map

Where is the best place to study Trigeminal Neuralgia and Treatments?

Among universities, judged by research, University of Copenhagen, Harvard University and Johns Hopkins University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19%fractional works in this field (log) →share of work in the world top 10% →University of Copenh…King's College LondonHarvard UniversityJohns Hopkins Univer…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University of CopenhagenDenmark 76.140.0%5.5×15 +8.5%
2Harvard UniversityUnited States 67.623.5%3.6×32 -14.7%
3Johns Hopkins UniversityUnited States 58.617.8%4.1×18 +42.7%
4King's College LondonUnited Kingdom 51.233.5%4.4×11 -35.3%
5Capital Medical UniversityChina 48.810.3%9.1×27 -10.0%
6Stanford UniversityUnited States 46.911.7%4.2×18 +87.8%
7Shanghai Jiao Tong UniversityChina 46.39.6%3.0×24 +13.3%
8Case Western Reserve UniversityUnited States 45.72.7%9.8×17 +198.0%
9Università Cattolica del Sacro CuoreItaly 44.722.1%7.8×10 +231.4%
10University College LondonUnited Kingdom 44.518.8%2.5×11 -25.0%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Trigeminal Neuralgia and Treatments, country by country

Is Trigeminal Neuralgia and Treatments research growing?

Output in 2022-2025 was 16% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Trigeminal Neuralgia and Treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Trigeminal Neuralgia and Treatments as a percentage of every work published that year, 0.013% in 2024.

still counting0.010%0.020%Trigeminal Neuralgia and Treatments0.014% in 202519801990200020102020

Fractional works of Trigeminal Neuralgia and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Trigeminal Neuralgia and Treatments9.9% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Trigeminal Neuralgia and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.